Search

Your search keyword '"Serena Torraca"' showing total 4 results
Start Over Author "Serena Torraca" Language english
4 results on '"Serena Torraca"'

1. Safety and effectiveness of low-protein diet supplemented with ketoacids in diabetic patients with chronic kidney disease

Author

Vincenzo Bellizzi, Patrizia Calella, Julia Nava Hernández, Verónica Figueroa González, Silvia Moran Lira, Serena Torraca, Rocio Urbina Arronte, Pietro Cirillo, Roberto Minutolo, and Rafael A. Montúfar Cárdenas

Subjects
Low-protein diet, Ketoacids, CKD, Diabetes, Protein-energy wasting, Insulin resistance, Diseases of the genitourinary system. Urology, RC870-923
Abstract

Abstract Background The impact of the low-protein diet on nutrition in CKD diabetics is uncertain. Methods The metabolic and nutritional effects of a low-protein (0.5–0.6 g/kg/d), normal-high energy (30–35 kcal/kg/d) diet supplemented with ketoacids (LPD-KA) were prospectively evaluated in CKD patients with (DM) and without (non-DM) diabetes mellitus. Results 197 patients on CKD stages 3–5 were enrolled. DM (n = 81) and non-DM (n = 116) were comparable for gender (Male 58 vs 55%), age (66 ± 9 vs 63 ± 18 years), renal function (eGFR 23 ± 13 vs 24 ± 13 mL/min). After 6-month, serum urea (DM: 131 ± 58 to 105 ± 49 mg/dl, p

Published
2018
Full Text
View/download PDF

2. Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology

Author

Biagio Di Iorio, Giorgina Barbara Piccoli, Silvio Borrelli, Roberto Minutolo, Giuseppe Quintaliani, Maura Ravera, Domenico Santoro, Marcora Mandreoli, Vincenzo Bellizzi, Luca De Nicola, Gianfranca Cabiddu, Serena Torraca, Ernesto Paoletti, Adamasco Cupisti, Giuseppe Conte, Bellizzi, Vincenzo, Conte, Giuseppe, Borrelli, Silvio, Cupisti, Adamasco, DE NICOLA, Luca, Di Iorio, Biagio R, Cabiddu, Gianfranca, Mandreoli, Marcora, Paoletti, Ernesto, Piccoli, Giorgina B, Quintaliani, Giuseppe, Ravera, Maura, Santoro, Domenico, Torraca, Serena, and Minutolo, Roberto

Subjects
Nephrology, medicine.medical_treatment, Biopsy, 030232 urology & nephrology, Angiotensin-Converting Enzyme Inhibitors, Position statement, 030204 cardiovascular system & hematology, Overweight, Sodium Chloride, Kidney, Diabete, Bicarbonate, CKD, Conservative therapy, Diabetes, Iron, Low protein diet, Obesity, Protein intake, RAAS, Renal biopsy, Salt intake, Renin-Angiotensin System, 0302 clinical medicine, Risk Factors, Diabetic Nephropathies, Renal Insufficiency, Chronic, Evidence-Based Medicine, Iron Deficiencies, Diet, Sodium-Restricted, Clinical Practice, medicine.symptom, medicine.medical_specialty, Dietary, Protein-Restricted, 03 medical and health sciences, Angiotensin Receptor Antagonists, Predictive Value of Tests, Renal Dialysis, Diabetes mellitus, Internal medicine, Diet, Protein-Restricted, medicine, Humans, Renal Insufficiency, Chronic, Sodium Chloride, Dietary, Intensive care medicine, Dialysis, Sodium-Restricted, business.industry, medicine.disease, Diet, Endocrinology, Position paper, business
Abstract

This position paper of the study group "Conservative treatment of Chronic Kidney Disease-CKD" of the Italian Society of Nephrology addresses major practical, unresolved, issues related to the conservative treatment of chronic renal disease. Specifically, controversial topics from everyday clinical nephrology practice which cannot find a clear, definitive answer in the current literature or in nephrology guidelines are discussed. The paper reports the point of view of the study group. Concise and practical advice is given on several common issues: renal biopsy in diabetes; dual blockade of the renin-angiotensin-aldosterone system (RAAS); management of iron deficiency; low protein diet; dietary salt intake; bicarbonate supplementation; treatment of obesity; the choice of conservative therapy vs. dialysis. For each topic synthetic statements, guideline-style, are reported.

Published
2017

3. Phosphorus, beverages, and chronic kidney disease

Author

Biagio Di Iorio, Maria Luisa Sirico, Serena Torraca, and Lucia Di Micco

Subjects
Nutrition and Dietetics, Materials science, Phosphorus, digestive, oral, and skin physiology, Medicine (miscellaneous), chemistry.chemical_element, lcsh:TX341-641, Phosphate, medicine.disease, lcsh:Nutritional diseases. Deficiency diseases, chemistry.chemical_compound, Inorganic phosphate, chemistry, medicine, Nutrition and Dietary Supplements, Food science, lcsh:Nutrition. Foods and food supply, lcsh:RC620-627, Kidney disease
Abstract

Biagio Di Iorio, Lucia Di Micco, Serena Torraca, Maria Luisa SiricoNephrology-Medicine Department, "A Landolfi" Hospital, Solofra, ItalyAbstract: Phosphate is present in food in two forms, ie, organic and inorganic phosphate salts, which are naturally present in food and as phosphates added for industrial and commercial reasons. There is also a high content of added phosphate in beverages, and phosphates in this form are highly absorbable. The real content of phosphate contained in beverages is often unrecognized, and nephrologists do not always take into account the amount of phosphorus that patients ingest in this form.Keywords: phosphorus, beverages, additive, diet

Published
2012

4. Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial.

Author

Bruno Cianciaruso, Andrea Pota, Antonio Pisani, Serena Torraca, Roberta Annecchini, Patrizia Lombardi, Alfredo Capuano, Paola Nazzaro, Vincenzo Bellizzi, and Massimo Sabbatini

Subjects
DIET in disease, KIDNEY diseases, CLINICAL trials, BLOOD plasma
Abstract

Background. International guidelines have not reached a complete agreement about the optimal amount of dietary proteins in chronic kidney disease(CKD). The aim of this study was to compare, with a randomized-controlled design, the metabolic effects of two diets with different protein content (0.55 vs 0.80 g/kg/day) in patients with CKD stages 4–5. Methods. Study design and sample size calculations were based on previously published experience of our group with low protein diet. The primary outcome of the study was the modification of serum urea nitrogen concentration. From 423 patients randomly assigned to the two diets 392 were analysed: 200 for the 0.55-Group and 192 for the 0.8-Group. The follow-up ranged 6–18 months. Results. Mean age was 61±18 years, 44% were women, mean eGFR was 18±7 ml/min/month. Three months after the dietary assignment and throughout the study period the two groups had a significantly different protein intake (0.72 vs 0.92 g/kg/day). The intention-to-treat analysis did not show any difference between the two groups. Compliance to the two test diets was significantly different (P vs 0.55-Group by 15% (P P P vs baseline) and were significantly lower than the 0.8-Group. The prescription of phosphate binders, allopurinol, bicarbonate supplements and diuretics resulted significantly less frequent in the 0.55-Group (P Conclusions. This study represents the first evidence that in CKD patients a protein intake of 0.55 g/kg/day, compared with a 0.8 g/kg/day, guarantees a better metabolic control and a reduced need of drugs, without a substantial risk of malnutrition. [ABSTRACT FROM AUTHOR]

Published
2008

Catalog

Books, media, physical & digital resources
See catalog results